PL3436463T3 - Postaci krystaliczne półwodzianu 2-[(2s)-1-azabicyklo[2.2.2]okt-2-ylo]-6-(3-metylo-1h-pirazol-4-ilo)tieno[3,2-d]pirymidyn-4(3h)-onu - Google Patents
Postaci krystaliczne półwodzianu 2-[(2s)-1-azabicyklo[2.2.2]okt-2-ylo]-6-(3-metylo-1h-pirazol-4-ilo)tieno[3,2-d]pirymidyn-4(3h)-onuInfo
- Publication number
- PL3436463T3 PL3436463T3 PL17719053T PL17719053T PL3436463T3 PL 3436463 T3 PL3436463 T3 PL 3436463T3 PL 17719053 T PL17719053 T PL 17719053T PL 17719053 T PL17719053 T PL 17719053T PL 3436463 T3 PL3436463 T3 PL 3436463T3
- Authority
- PL
- Poland
- Prior art keywords
- hemihydrate
- thieno
- azabicyclo
- pyrazol
- pyrimidin
- Prior art date
Links
- ZEVOHYVKGUGTDT-DHHADUQMSA-N 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)-3H-thieno[3,2-d]pyrimidin-4-one hydrate Chemical compound O.Cc1[nH]ncc1-c1cc2[nH]c(nc(=O)c2s1)[C@@H]1CC2CCN1CC2.Cc1[nH]ncc1-c1cc2[nH]c(nc(=O)c2s1)[C@@H]1CC2CCN1CC2 ZEVOHYVKGUGTDT-DHHADUQMSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662314080P | 2016-03-28 | 2016-03-28 | |
| US201662367842P | 2016-07-28 | 2016-07-28 | |
| PCT/US2017/024226 WO2017172565A1 (en) | 2016-03-28 | 2017-03-27 | Crystalline forms of 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h- pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-one hemihydrate |
| EP17719053.5A EP3436463B1 (en) | 2016-03-28 | 2017-03-27 | Crystalline forms of 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h- pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-one hemihydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3436463T3 true PL3436463T3 (pl) | 2021-11-08 |
Family
ID=58609973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17719053T PL3436463T3 (pl) | 2016-03-28 | 2017-03-27 | Postaci krystaliczne półwodzianu 2-[(2s)-1-azabicyklo[2.2.2]okt-2-ylo]-6-(3-metylo-1h-pirazol-4-ilo)tieno[3,2-d]pirymidyn-4(3h)-onu |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11746109B2 (pl) |
| EP (1) | EP3436463B1 (pl) |
| JP (2) | JP6918824B2 (pl) |
| CN (1) | CN108779126B (pl) |
| CA (1) | CA3016708A1 (pl) |
| DK (1) | DK3436463T3 (pl) |
| ES (1) | ES2884398T3 (pl) |
| PL (1) | PL3436463T3 (pl) |
| PT (1) | PT3436463T (pl) |
| TW (1) | TWI738748B (pl) |
| WO (1) | WO2017172565A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016378723B2 (en) | 2015-12-22 | 2021-09-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
| PL3436463T3 (pl) * | 2016-03-28 | 2021-11-08 | Takeda Pharmaceutical Company Limited | Postaci krystaliczne półwodzianu 2-[(2s)-1-azabicyklo[2.2.2]okt-2-ylo]-6-(3-metylo-1h-pirazol-4-ilo)tieno[3,2-d]pirymidyn-4(3h)-onu |
| JP6825163B2 (ja) * | 2017-05-21 | 2021-02-03 | ゼンジ リサーチ ラボラトリーズＺｅｎｊｉ Ｒｅｓｅａｒｃｈ Ｌａｂｏｒａｔｏｒｉｅｓ | 抗癌剤としての置換［５，６］シクロ−４（３ｈ）−ピリミジノン |
| MA49458A (fr) | 2017-06-21 | 2020-04-29 | SHY Therapeutics LLC | Composés interagissant avec la superfamille ras destinés à être utilisés dans le traitement de cancers, de maladies inflammatoires, de rasopathies et de maladies fibrotiques |
| WO2019194319A1 (en) | 2018-04-02 | 2019-10-10 | Takeda Pharmaceutical Company Limited | Process for the synthesis of 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6- (3-methyl-1 h-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-one |
| TWI846703B (zh) * | 2018-06-19 | 2024-07-01 | 日商武田藥品工業股份有限公司 | 癌症治療方法 |
| IL280130B2 (en) * | 2018-07-19 | 2024-11-01 | Takeda Pharmaceuticals Co | Pharmaceutical compositions with a cdc7 inhibitor |
| EP3898609A1 (en) | 2018-12-19 | 2021-10-27 | Shy Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| EP3978501A4 (en) * | 2019-05-30 | 2023-05-24 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | TETRACYCLIC COMPOUNDS AS CDC7 INHIBITORS |
| KR20220061088A (ko) * | 2019-06-24 | 2022-05-12 | 노렉스, 인크. | 고체 형태의 tert-부틸 (S)-2-((2S,3R)-1-아미노-3-히드록시-1-옥소부탄-2-일)-1-옥소-2,5-디아자스피로[3.4]옥탄-5-카르복실레이트 및 제조 방법 |
| EP3999050A2 (en) | 2019-07-19 | 2022-05-25 | Takeda Pharmaceutical Company Limited | Combination therapy for cancer treatment |
| WO2022111729A1 (zh) * | 2020-11-30 | 2022-06-02 | 正大天晴药业集团股份有限公司 | 作为Cdc7抑制剂的盐型及其晶型 |
| JP2024506314A (ja) | 2021-02-08 | 2024-02-13 | 武田薬品工業株式会社 | がん治療のための併用療法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011216404B2 (en) | 2010-02-17 | 2016-04-07 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| PL3436463T3 (pl) * | 2016-03-28 | 2021-11-08 | Takeda Pharmaceutical Company Limited | Postaci krystaliczne półwodzianu 2-[(2s)-1-azabicyklo[2.2.2]okt-2-ylo]-6-(3-metylo-1h-pirazol-4-ilo)tieno[3,2-d]pirymidyn-4(3h)-onu |
-
2017
- 2017-03-27 PL PL17719053T patent/PL3436463T3/pl unknown
- 2017-03-27 JP JP2018550532A patent/JP6918824B2/ja active Active
- 2017-03-27 EP EP17719053.5A patent/EP3436463B1/en active Active
- 2017-03-27 TW TW106110102A patent/TWI738748B/zh active
- 2017-03-27 WO PCT/US2017/024226 patent/WO2017172565A1/en not_active Ceased
- 2017-03-27 CA CA3016708A patent/CA3016708A1/en active Pending
- 2017-03-27 ES ES17719053T patent/ES2884398T3/es active Active
- 2017-03-27 CN CN201780018847.4A patent/CN108779126B/zh active Active
- 2017-03-27 PT PT177190535T patent/PT3436463T/pt unknown
- 2017-03-27 DK DK17719053.5T patent/DK3436463T3/da active
- 2017-03-27 US US16/088,096 patent/US11746109B2/en active Active
-
2020
- 2020-04-27 JP JP2020078643A patent/JP2020143076A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW201736383A (zh) | 2017-10-16 |
| JP2019510033A (ja) | 2019-04-11 |
| PT3436463T (pt) | 2021-09-06 |
| JP6918824B2 (ja) | 2021-08-11 |
| CN108779126B (zh) | 2021-07-16 |
| CN108779126A (zh) | 2018-11-09 |
| DK3436463T3 (da) | 2021-08-30 |
| CA3016708A1 (en) | 2017-10-05 |
| US20230102273A1 (en) | 2023-03-30 |
| EP3436463B1 (en) | 2021-06-23 |
| TWI738748B (zh) | 2021-09-11 |
| JP2020143076A (ja) | 2020-09-10 |
| ES2884398T3 (es) | 2021-12-10 |
| US11746109B2 (en) | 2023-09-05 |
| WO2017172565A1 (en) | 2017-10-05 |
| EP3436463A1 (en) | 2019-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3436463T (pt) | Formas cristalinas de 2-[(2s)-1-azabiciclo[2.2.2]oct-2- il]-6-(3-metil-1h-pirazol-4-il)tieno[3,2-d]pirimidin-4(3h)- ona hemihidratada | |
| IL266897B (en) | History of thiano[2,3–d]pyrimidines for the treatment of viral infections | |
| IL265757A (en) | H1-Imidazo[5,4-b]pyridine-2(h3)-converted ions and their use as glun2b receptor modulators | |
| IL266170A (en) | A process for the preparation of pyrazolo[1,5-a]pyrimidines and their salts | |
| PL3345907T3 (pl) | Związki pirazolo[3,4-d]pirymidynowe lub ich sole | |
| PL3379933T3 (pl) | KOMPOZYCJE GRZYBOBÓJCZE ZAWIERAJĄCE POCHODNE 2,4-DIOKSO-1,4-DIHYDROTIENO[2,3-d]PIRYMIDYNY | |
| ZA201705802B (en) | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives | |
| PL3555097T3 (pl) | Związki imidazo[4,5-d]pirolo[2,3-b]pirydynowe jako inhibitory kinaz janusowych | |
| IL249706A0 (en) | Thiano[3,2-d]pyrimidine, fluoro[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines are useful in the treatment of respiratory syncytial virus infections | |
| IL255305A0 (en) | Synthesis of h1-pyrrolo[3,2-b]pyridine derivatives that modulate kinases | |
| SG11201704512PA (en) | 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection | |
| HRP20182007T1 (hr) | Derivati 3-okso-2,3,5,8-tetrahidro-[1,2,4]triazolo[4,3-a]pirimidina za liječenje respiratornih bolesti | |
| ZA201605666B (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| EP3472169A4 (en) | PROCESS FOR PREPARING 4-CHLORO-7H-PYRROLO [2,3-D] PYRIMIDINE | |
| IL267801B1 (en) | Process for the preparation of 3-disubstituted 5-amino-h6-thiazolo[5,4-d]pyrimidine-7,2-dione compounds | |
| GB201802644D0 (en) | Monocyclic,thieno, pyrido and pyrrolo pyrimidine compounds and methods of use and manufacture of the same | |
| MA46937A (fr) | 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones en tant qu'inhibiteurs de kinases dépendantes des cyclines | |
| PT3459953T (pt) | Novo derivado de 5h-pirrolo[2,3-d]pirimidin-6(7h)-ona | |
| IL265985A (en) | Process for the preparation of (3s,4s)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3h-imidazo[4,5-c]pyridine-5(4h)-carboxylate | |
| HUE050298T2 (hu) | Pirazolo[3,4-D]pirimidin vegyületek vagy annak sói | |
| HK40012542A (en) | Substituted 1h-imidazo[4,5-b]pyridin-2(3h)-ones and their use as glun2b receptor modulators | |
| ZA201702297B (en) | A process for the preparation of 3-phenyl/heteroaryl-6-phenoxy-8-alkylamino-imidazo[1,2-b]pyridazine derivatives | |
| HK40010258A (en) | Process for the preparation of (3s,4s)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3h-imidazo[4,5-c]pyridine-5(4h)-carboxylate |